Monograph
C07AB09 - Esmolol |
Not porphyrinogenic |
NP |
Rationale
Beta-blocker. Non-CYP metabolism. Two references: use.
Chemical description
Beta-receptor blocking agent. Metabolized by esterase in the red blood cells, the metabolite excreted in urine. South African list: use. EPI: safe (betablockers).
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Brevibloc · Brevibloc 10 mg/ml, oplossing voor infusie · Brevibloc 10 mg/ml, oplossing voor injectie · Esmolol · Esmolol HCl Hikma 10 mg/ml, oplossing voor injectie · Esmolol HCl LYO Orpha 2500 mg poeder voor concentraat voor oplossing voor infusie · Esmolol HCl Orpha 100 mg/10 ml oplossing voor injectieBelgium
Brevibloc · Brevibloc 10 mg/ml sol. inj. i.v. flac. · Brevibloc 10 mg/ml sol. perf. i.v.United Kingdom
Brevibloc Concentrate · Brevibloc Concentrate 2.5g/10ml solution for infusion ampoules · Brevibloc Premixed · Brevibloc Premixed 100mg/10ml solution for injection vials · Brevibloc Premixed 2.5g/250ml infusion bags · Esmolol · Esmolol 100mg/10ml solution for injection vials · Esmolol 2.5g/250ml solution for infusion bottles · Esmolol hydrochloride 2.5g powder for concentrate for solution for infusion vials · Esmolol hydrochloride · Esmolol hydrochloride 100mg/10ml solution for injection vials · Esmolol hydrochloride 2.5g/10ml concentrate for solution for infusion ampoulesDenmark
BreviblocNorway
BreviblocPoland
Esmocard 100 mg/10 ml · Esmocard LyoLuxembourg
BREVIBLOC · BREVIBLOC-10MG/MLFinland
Brevibloc
© NAPOS 2024